Table 3.
Okay with personal enrollment under EFIC (%agree)* | Okay with EFIC usage in general in this study (%agree) † | Glad about inclusion in this study (%agree) ‡ | |||||
---|---|---|---|---|---|---|---|
n (%) | p-value | n (%) | p-value | n (%) | p-value | ||
Respondent Type | Patient | 26 (84%) | 0.297 | 22 (71%) | 0.902 | 23 (74%) | 0.079 |
Surrogate | 40 (74%) | 39 (72%) | 48 (89%) | ||||
Gender | Male | 26 (67%) | 0.025 | 22 (56%) | 0.004 | 30 (77%) | 0.130 |
Female | 40 (87%) | 39 (85%) | 41 (89%) | ||||
Age | <30 | 11 (73%) | 0.750 | 11 (73%) | 0.862 | 11 (73%) | 0.038 |
31–50 | 25 (81%) | 21 (68%) | 23 (74%) | ||||
51–70 | 26 (79%) | 25 (76%) | 32 (97%) | ||||
>70 | 3 (60%) | 3 (60%) | 4 (80%) | ||||
Refused | 1 (100%) | 1 (100%) | 1 (100%) | ||||
Race | White | 49 (83%) | 0.029 | 45 (76%) | 0.047 | 49 (83%) | 0.458 |
Black | 6 (55%) | 5 (45%) | 8 (73%) | ||||
Hispanic/Latino | 6 (100%) | 6 (100%) | 5 (83%) | ||||
Other | 5 (56%) | 5 (56%) | 9 (100%) | ||||
Education | ≤ High School | 32 (78%) | 0.932 | 30 (73%) | 0.781 | 31 (76%) | 0.057 |
> High School | 34 (77%) | 31 (70%) | 40 (91%) | ||||
Income | < $5,000 | 4 (67%) | 0.519 | 2 (33%) | 0.146 | 4 (67%) | 0.429 |
$5,000–$20,000 | 9 (82%) | 9 (82%) | 9 (82%) | ||||
$20,000–$40,000 | 17 (89%) | 17 (89%) | 17 (89%) | ||||
$40,000–$60,000 | 10 (83%) | 9 (75%) | 11 (92%) | ||||
$60,000–$80,000 | 10 (83%) | 9 (75%) | 11 (92%) | ||||
> $80,000 | 11 (61%) | 10 (56%) | 14 (78%) | ||||
Don’t know | 3 (75%) | 3 (75%) | 2 (50%) | ||||
Refused | 2 (67%) | 2 (67%) | 3 (100%) | ||||
Prior research experience | Yes | 4 (67%) | 0.612 | 4 (67%) | 1.000 § | 5 (83%) | 1.000 § |
No | 62 (78%) | 57 (72%) | 66 (84%) | ||||
Time from enrollment | 0–192 days (median) | 38 (88%) | 0.0163 | 33 (77%) | 0.320 | 36 (84%) | 0.962 |
>192 days | 28 (67%) | 28 (67%) | 35 (83%) |